Top ▲
Unless otherwise stated all data on this page refer to the human proteins. Gene information is provided for human (Hs), mouse (Mm) and rat (Rn).
« Hide More detailed introduction
Retinoic acid receptors (nomenclature as agreed by the NC-IUPHAR Subcommittee on Nuclear Hormone Receptors [1,6]) are nuclear hormone receptors of the NR1B family activated by the vitamin A-derived agonists tretinoin (ATRA) and alitretinoin, and the RAR-selective synthetic agonists TTNPB and adapalene. BMS493 is a family-selective antagonist [7].
Retinoic acid receptor-α / NR1B1 C Show summary » More detailed page |
Retinoic acid receptor-β / NR1B2 C Show summary » More detailed page |
Retinoic acid receptor-γ / NR1B3 C Show summary » More detailed page |
Database page citation:
1B. Retinoic acid receptors. Accessed on 02/11/2024. IUPHAR/BPS Guide to PHARMACOLOGY, http://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=85.
Concise Guide to PHARMACOLOGY citation:
Alexander SPH, Cidlowski JA, Kelly E, Mathie AA, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Davies JA et al. (2023) The Concise Guide to PHARMACOLOGY 2023/24: Nuclear hormone receptors. Br J Pharmacol. 180 Suppl 2:S223-240.
Ro 41-5253 has been suggested to be a PPARγ agonist [14]. LE135 is an antagonist with selectivity for RARα and RARβ compared with RARγ [11].